Concepedia

P Fischer

PF

Statistics

Publications

6

Citations

359

H-Index

6

Active since

1994

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

P Fischer is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacotherapy, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

1994–2021

6

Publications

6

Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.

Robert J. Motzer, Dean F. Bajorin, Lawrence H. Schwartz et al. · Journal of Clinical Oncology · 1994 · 174 citations

Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma.

Robert J. Motzer, P Lyn, P Fischer et al. · Journal of Clinical Oncology · 1995 · 79 citations

Phase I trial of bevacizumab plus sunitinib in patients with metastatic renal cell carcinoma

Darren R. Feldman, Michelle S. Ginsberg, Michael Baum et al. · Journal of Clinical Oncology · 2008 · 42 citations

, , +10

Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)

Darren R. Feldman, G. Varuni Kondagunta, Ellen A. Ronnen et al. · Journal of Clinical Oncology · 2007 · 34 citations

, , +17

Evaluating the Spectrum of Cognitive-Motor Relationships During Dual-Task Jump Landing

P Fischer, Keith A. Hutchison, James Becker et al. · Journal of Applied Biomechanics · 2021 · 19 citations

, , +22

1–5 of 6